ESPR earnings: real EPS beat/miss history, analyst consensus Hold, P/E -131.40. Updated 2026-07-23.
Esperion Therapeutics (ESPR) Research Hub
Esperion Therapeutics (ESPR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-07-14, shares last closed at 3.18 USD (-0.31%), in a uptrend — price above rising 50-DMA, 50-DMA above 200-DMA. Valuation: trailing P/E -131.40, market cap 0.66B. This hub links to the full technical, earnings and options research available for ESPR.
Last updated 2026-07-14 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.18 USD (-0.31%) |
| 52-week range | 1.13 USD – 4.18 USD |
| Trend regime | Uptrend |
| 14-day RSI | 58.3 (Bullish) |
| Trailing P/E | -131.40 |
| Market cap | 0.66B |
| Dividend yield | 99.37% |
Available research for ESPR
Covered Call on ESPR: how it works, illustrative setup around the real 3.18 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ESPR: how it works, illustrative setup around the real 3.18 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ESPR: how it works, illustrative setup around the real 3.18 USD price, max profit/loss, breakeven and when to use it. Educational.
ESPR technical analysis: uptrend, last 3.18 USD, RSI 58.3, 52w range 1.13 USD–4.18 USD, real support/resistance. Updated 2026-07-14.
Frequently asked questions
What sector is ESPR in?
Esperion Therapeutics (ESPR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ESPR in an uptrend or downtrend?
As of 2026-07-14, ESPR is in a uptrend — price above rising 50-DMA, 50-DMA above 200-DMA. See the full technical research page for support and resistance levels.
What is ESPR's trailing P/E ratio?
ESPR's trailing P/E is -131.40, with a market cap of 0.66B. See the earnings research page for full valuation detail.